Cargando…

Human Epidermal Growth Factor Receptor-2 Gastric Adenocarcinoma: Expanding Therapy of a Recognized Target

SIMPLE SUMMARY: Human epidermal growth factor receptor-2 (HER2) is a well-known target for approximately 15% of gastric adenocarcinomas (GACs). Although a plethora of HER2-targeted agents are marketed, currently only two agents are approved for GAC. These two agents are used only in the metastatic s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rogers, Jane E., Yamashita, Kohei, Sewastjanow-Silva, Matheus, Trail, Allison, Waters, Rebecca E., Ajani, Jaffer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650285/ https://www.ncbi.nlm.nih.gov/pubmed/37958354 http://dx.doi.org/10.3390/cancers15215180

Ejemplares similares

Current Immune Checkpoint Inhibitor Genetic Biomarker Exploration in Gastrointestinal Tumors
por: Rogers, Jane E., et al.
Publicado: (2022)

Can You Establish the Cause of This Patient's Shortness of Breath?
por: Trail, Allison, et al.
Publicado: (2023)

Recent advances in the management of gastric adenocarcinoma patients
por: Rogers, Jane E, et al.
Publicado: (2023)

Preoperatively Treated Diffuse-Type Gastric Adenocarcinoma: Glucose vs. Other Energy Sources Substantially Influence Prognosis and Therapy Response
por: Abdelhakeem, Ahmed A., et al.
Publicado: (2021)

Challenges and Prospects of Patient-Derived Xenografts for Cancer Research
por: Jin, Jiankang, et al.
Publicado: (2023)

Trimodality treatment in gastric and gastroesophageal junction cancers: Current approach and future perspectives
por: Charalampakis, Nikolaos, et al.
Publicado: (2022)

Therapeutic Advances in the Treatment of Gastroesophageal Cancers
por: Li, Jenny J., et al.
Publicado: (2023)

Treatment of localized gastric and gastroesophageal adenocarcinoma: the role of accurate staging and preoperative therapy
por: Badgwell, Brian, et al.
Publicado: (2017)

Recent advances in treating oesophageal cancer
por: Harada, Kazuto, et al.
Publicado: (2020)

Recent advances in the management of gastric adenocarcinoma patients
por: Harada, Kazuto, et al.
Publicado: (2018)

GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma
por: Li, Yuan, et al.
Publicado: (2022)

Can We Understand the Clinical Biology of Gastric Cancer and Exploit it? May be, but It is a Challenge!
por: Ajani, Jaffer A.
Publicado: (2007)

Programmed death ligand‐1 expression in gastrointestinal cancer: Clinical significance and future challenges
por: Yamashita, Kohei, et al.
Publicado: (2020)

Proteomic profiling of key signatures from gastric lesions to early gastric cancer
por: Fan, Yibo, et al.
Publicado: (2021)

Recent trend in gastric cancer treatment in the USA
por: Harada, Kazuto, et al.
Publicado: (2018)

Recent advances in preoperative management of esophageal adenocarcinoma
por: Harada, Kazuto, et al.
Publicado: (2017)

Treatment of Gastric Adenocarcinoma May Differ Among Hospital Types in the United States, a Report from the National Cancer Data Base
por: Reid-Lombardo, Kaye M., et al.
Publicado: (2007)

Review of docetaxel in the treatment of gastric cancer
por: Tetzlaff, Eric D, et al.
Publicado: (2008)

Targeted literature review of the global burden of gastric cancer
por: Casamayor, Montserrat, et al.
Publicado: (2018)

Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma
por: Allen, Casey J., et al.
Publicado: (2020)

Customization of therapy for gastroesophageal adenocarcinoma patients
por: Mizrak Kaya, Dilsa, et al.
Publicado: (2018)

An Indigenous critique: Expanding sociology and recognizing unique Indigenous knowledge
por: Mackay, Ried E
Publicado: (2022)

Proteogenomic landscape of gastric adenocarcinoma peritoneal metastases
por: Zhao, Shuangtao, et al.
Publicado: (2023)

The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective
por: Xu, Yan, et al.
Publicado: (2019)

Detection and Significance of Human Epidermal Growth Factor Receptor 2 Expression in Gastric Adenocarcinoma
por: Halder, Sutapa, et al.
Publicado: (2017)

Gastric adenocarcinoma expressing human epidermal growth factor receptor in South Asian population
por: Shabbir, Asma, et al.
Publicado: (2018)

A Case of a Chronic Expanding Hematoma Caused by an Epidermal Cyst
por: Kuwahara, Masamitsu, et al.
Publicado: (2023)

Clinically conserved genomic subtypes of gastric adenocarcinoma
por: Jeong, Yun Seong, et al.
Publicado: (2023)

Serum miR-331-3p predicts tumor recurrence in esophageal adenocarcinoma
por: Gu, Jianchun, et al.
Publicado: (2018)

Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer
por: Guan, Xiaoxiang, et al.
Publicado: (2009)

Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma
por: Hedner, Charlotta, et al.
Publicado: (2016)

Prognostic significance of Human epidermal growth factor receptor-2 expression in patients with resectable gastric adenocarcinoma
por: Kim, Hyeongbin, et al.
Publicado: (2019)

A study of human epidermal growth factor receptor 2 overexpression by immunohistochemistry in patients with gastric adenocarcinoma
por: ABOOD, RAFID A., et al.
Publicado: (2023)

The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer
por: Guan, Xiaoxiang, et al.
Publicado: (2009)

ERCC1 and ERCC2 Variants Predict Survival in Gastric Cancer Patients
por: Li, Yangkai, et al.
Publicado: (2013)

Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization
por: Gee, Julia MW, et al.
Publicado: (2003)

Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?
por: Yamashita, Kohei, et al.
Publicado: (2019)

Phase III Study to Evaluate Efficacy and Safety of Andecaliximab With mFOLFOX6 as First-Line Treatment in Patients With Advanced Gastric or GEJ Adenocarcinoma (GAMMA-1)
por: Shah, Manish A., et al.
Publicado: (2021)

Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma.
por: Filipe, M. I., et al.
Publicado: (1995)

Dedifferentiated endometrioid adenocarcinoma: An under-recognized but aggressive tumor?()
por: Wu, Emily S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_c8576clpmraqdcuoaih8jf3c15